Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases with unmet medical needs. The company uses its XmAb technology pla... Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045 and XmAb13676. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates. Show more
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and other serious diseases, today announced that company...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.45 | -1.8711018711 | 24.05 | 24.94 | 22.76 | 500024 | 24.43324033 | CS |
4 | -2.98 | -11.2114371708 | 26.58 | 27.24 | 22.74 | 835395 | 24.77831823 | CS |
12 | 3.75 | 18.8916876574 | 19.85 | 27.24 | 19.07 | 606707 | 23.72691907 | CS |
26 | 4.65 | 24.5382585752 | 18.95 | 27.24 | 15.31 | 559860 | 21.47051171 | CS |
52 | 2.43 | 11.4785073217 | 21.17 | 27.24 | 15.31 | 621439 | 21.6449843 | CS |
156 | -17.16 | -42.1000981354 | 40.76 | 42.3 | 15.31 | 445317 | 24.18090125 | CS |
260 | -11.69 | -33.125531312 | 35.29 | 58.345 | 15.31 | 388410 | 27.98619145 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales